SEARCH

SEARCH BY CITATION

References

  • 1
    Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1: 106112.
  • 2
    Trofe J, Buell JF, First MR, Hanaway MJ, Beebe TM, Woodle ES. The role of immunosuppression in lymphoma. Recent Results Cancer Res 2002; 159: 5566.
  • 3
    Birkeland SA, Hamilton-Dutoit S. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 2003; 76: 984988.
  • 4
    Funch DP, Brady J, Ko HH, Dreyer NA, Walker AM. Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients. Recent Results Cancer Res 2002; 159: 8188.
  • 5
    Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001; 88: 13301334.DOI: 10.1046/j.0007-1323.2001.01924.x
  • 6
    Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003; 31: 145155.DOI: 10.1038/sj.bmt.1703806
  • 7
    Leblond V, Dhedin N, Mamzer Bruneel MF, Choquet S, Hermine O, Porcher R et al. Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. J Clin Oncol 2001; 19: 772778.
  • 8
    Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001; 71: 10761088.DOI: 10.1097/00007890-200104270-00012
  • 9
    Choquet S, Mamzer BM, Hermine O, Porcher R, Nguyen QS, Davi F et al. Identification of prognostic factors in post-transplant lymphoproliferative disorders. Recent Results Cancer Res 2002; 159: 6780.
  • 10
    Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147156.
  • 11
    Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999; 68: 18511854.DOI: 10.1097/00007890-199912270-00006
  • 12
    Shiel A. Cancer in Dialysis and Transplant Patients. In: MorrisPJ, ed. Kidney Transplantation Principles and Practice. 5th Ed. Philadelphia : WB Saunders; 2001. p. 558570.
  • 13
    Preiksaitis JK. Epstein–Barr virus infection and malignancy in solid organ transplant recipients: strategies for prevention and treatment. Transpl Infect Dis 2001; 3: 5659.DOI: 10.1034/j.1399-3062.2001.003002056.x
  • 14
    Green M, Reyes J, Webber S, Rowe D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein–Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 2001; 3: 97103.DOI: 10.1034/j.1399-3062.2001.003002097.x
  • 15
    Holmes RD, Sokol RJ. Epstein–Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 2002; 6: 456464.DOI: 10.1034/j.1399-3046.2002.02043.x
  • 16
    Cosio FG, Nuovo M, Delgado L, Yearsley M, Porcu P, Caligiuri M et al. EBV kidney allograft infection: possible relationship with a peri-graft localization of PTLD. Am J Transplant 2004; 4: 116123.
  • 17
    Ho M, Jaffe R, Miller G, Breinig MK, Dummer JS, Makowka L et al. The frequency of Epstein–Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719727.
  • 18
    Hanto DW, Frizzera G, Gajl-Peczalska J, Purtilo DT, Klein G, Simmons RL et al. The Epstein–Barr virus (EBV) in the pathogenesis of posttransplant lymphoma. Transplant Proc 1981; 13: 756760.
  • 19
    Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 2004; 22: 262268.DOI: 10.1200/JCO.2004.08.039
  • 20
    Au HJ, Mulder KE, Fields AL. Systematic review of management of colorectal cancer in elderly patients. Clin Colorectal Cancer 2003; 3: 165171.